Clinical Trial Results:
A phase IV, 16 weeks, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to assess the efficacy and safety of oral Tribulus terrestris (Tribestan®) in men with erectile dysfunction (mild to moderate) and/or secondary hypoactive sexual desire (low libido)
Summary
|
|
EudraCT number |
2008-001998-15 |
Trial protocol |
BG |
Global completion date |
29 Mar 2013
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
01 Apr 2016
|
First version publication date |
01 Apr 2016
|
Other versions |
|
Summary report(s) |
Synopsis CT results_Trib_01_08 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.